EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, ATAI: Atai Life Sciences N.V.

17 Oct 25 19:59
LAST:

6.867

CHANGE:
 0.97		OPEN:
5.760		HIGH:
6.880		ASK:
6.000		VOLUME:
29.89M
CHG(%):
17.70		PREV:
5.480		LOW:
5.310		BID:
0.010		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
17 Oct 255.5306.5455.3806.45031.26M
16 Oct 256.0006.0905.4755.4806.64M
15 Oct 256.1206.3005.8355.9606.31M
14 Oct 255.3506.2405.3406.0009.79M
13 Oct 255.2105.4305.0605.4005.25M
10 Oct 255.4505.4825.0905.1004.61M
09 Oct 255.6505.8305.3625.4504.62M
08 Oct 255.5705.6135.3805.5803.91M
07 Oct 255.5205.6905.3805.5404.24M
06 Oct 255.3005.5255.1605.4704.55M

COMPANY PROFILE

Name:Atai Life Sciences N.V.
About:Atai Life Sciences N.V., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada. The company develops BPL-003, an intranasal formulation of the benzoate salt form of mebufotenin that is in Phase 2a and 2b clinical studies for treatment resistant depression (TRD) and alcohol use disorder; RL-007, an orally bioavailable compound, which is a pro-cognitive neuromodulator in Phase 2b trial for cognitive impairment associated with schizophrenia; and ELE-101, a serotonergic psychedelic in Phase 2a trial for the treatment of major depressive disorder. It is also developing VLS-01, an oral transmucosal film formulation of N,N-Dimethyltryptamine in Phase 2 clinical study to treat TRD; EMP-01, an oral formulation of R-3,4-methylenedioxy-methamphetamine that is in Phase 2 clinical study for social anxiety disorder; and EGX-A & EGX-B, which are non-hallucinogenic 5-HT2A receptor agonists in preclinical studies for TRD. In addition, the company offers COMP360 for psilocybin therapy; and GRX-917 for the treatment of anxiety, depression, and various neurological disorders. ATAI Life Sciences N.V. was founded in 2018 and is headquartered in Amstelveen, The Netherlands.
Sector:Healthcare
Industry:Biotechnology
Address:Prof. J.H. Bavincklaan 7, Amstelveen, Netherlands, 1183 AT
Website:https://atai.com
CIK:0001840904
ISIN:NL0015000DX5
FIGI:BBG0107FR3K9

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:5.8617.2%
MA10:5.6421.7%
MA20:5.4625.8%
MA50:4.8641.4%
MA100:3.8478.7%
MA200:2.73151.2%
STO9:93.41 
STO14:93.41 
RSI14:63.81 
MTM14:1.16
ROC14:0.22 
ATR:0.49 
Week High:6.554.9%
Week Low:5.0635.7%
Month High:6.554.9%
Month Low:4.58151.2%
Year High:6.554.9%
Year Low:1.04560.3%
Volatility:21.83